Anodyne Medical Device Unveils New Brand Identity

CORAL SPRINGS, Fla., May 4 /PRNewswire/ -- Anodyne Medical Device, Inc., a subsidiary of Compass Diversified Holdings (Nasdaq: CODI), announced today it has launched a corporate rebranding campaign highlighted by the introduction of a new company name, Tridien Medical. The new brand identity is designed to reflect the company's large and diverse platform of medical therapeutic support surfaces and patient positioning devices serving the acute care, long-term care and home health care markets.

Abbey Daniels, Chief Executive Officer of Tridien Medical, commented, "Since our inception in 2006, we have experienced significant growth following the strategic acquisitions of AMF Support Surfaces, Anatomic Concepts, Primatech Medical and SenTech Medical Systems. With an expanding portfolio of leading powered and non-powered therapeutic surfaces, we recognized the need to consolidate our identity in a manner consistent with our corporate transformation for the benefit of our customers, employees and other key stakeholders. Our new brand represents the 'Power of One,' enabling Tridien Medical to become a more cohesive organization that takes full advantage of our operating synergies."  

Ms. Daniels added, "The new Tridien Medical name and logo, which includes three embedded resting people, celebrates our three guiding principles: Innovation, Quality and Service. Our commitment to delivering unsurpassed innovation, the highest quality products and superior service has been the hallmark of our success and will continue to serve us well in the future. Going forward, we intend to leverage our new corporate identity to build greater brand equity and further strengthen our leadership position in the medical support surfaces industry."

Tridien Medical plans to unveil its new corporate brand, and introduce new therapeutic technologies, at the Medtrade Spring Conference on May 11-13, 2010, at the Sands Expo and Convention Center, Booth 613, in Las Vegas, NV. In addition to the new company name, the rebranding campaign includes a new website at www.Tridien.com, marketing collateral, rebranded products, and more, to be rolled out over the next 12 months.

About Tridien Medical, Inc.

Based in Coral Springs, FL, Tridien Medical, Inc. is a leading designer and manufacturer of medical therapeutic support surfaces and patient positioning devices, which are primarily used for the prevention and treatment of pressure wounds experienced by patients with limited to no mobility. Tridien offers bi-coastal design and manufacturing facilities in California and Florida. Tridien's stringent quality management system guides the company's daily operations and each operation is certified to ISO-13485.

About Compass Diversified Holdings ("CODI")

Compass Diversified Holdings ("CODI") owns and manages a diverse family of established North American middle market businesses.  Each of its seven subsidiaries is a leader in their niche market.  

CODI maintains controlling ownership interests in each of its subsidiaries in order to maximize its ability to impact long term cash flow generation and value. The Company provides both debt and equity capital for its subsidiaries, contributing to their financial and operating flexibility. CODI's success is driven by its disciplined approach in identifying and evaluating potential acquisition opportunities, proactive and consistent engagement with subsidiary management teams and, in certain cases, the monetization of its subsidiaries when it believes that doing so will maximize shareholder returns.  CODI utilizes the cash flows generated by its subsidiaries to invest in the long-term growth of the Company and to make cash distributions to its owners.

This press release may contain certain forward-looking statements, including statements with regard to the future performance of the Company. Words such as "believes," "expects," "projects," and "future" or similar expressions, are intended to identify forward-looking statements. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. Certain factors could cause actual results to differ materially from those projected in these forward-looking statements, and some of these factors are enumerated in the risk factor discussion in the Form 10-K filed by CODI with the Securities and Exchange Commission for the year ended December 31, 2009 and other filings with the Securities and Exchange Commission. CODI undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE Tridien Medical